A detailed history of Legacy Wealth Planning, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Legacy Wealth Planning, LLC holds 1,532 shares of ABBV stock, worth $311,838. This represents 0.34% of its overall portfolio holdings.

Number of Shares
1,532
Previous 1,532 -0.0%
Holding current value
$311,838
Previous $235,000 12.34%
% of portfolio
0.34%
Previous 0.34%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 26, 2022

SELL
$137.62 - $174.96 $1,238 - $1,574
-9 Reduced 0.58%
1,532 $235,000
Q1 2022

May 10, 2022

BUY
$131.98 - $163.75 $203,381 - $252,338
1,541 New
1,541 $250,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $360B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Legacy Wealth Planning, LLC Portfolio

Follow Legacy Wealth Planning, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Legacy Wealth Planning, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Legacy Wealth Planning, LLC with notifications on news.